Skip to main content Skip to main content
Go to homepage

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma COG –ANLB00B1

Biomarkers in Tumor Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

Description:

For complete study details, please visit the study on clinicaltrials.gov.

Interested in participating?
We are currently recruiting
Study Sponsor:

Children's Oncology Group

Full IRB Study Title:
ANBL00B1 Neuroblastoma Biology Studies
IRB Study ID:
1108245
If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org

Lead Investigator
Steven Kuerbitz, MD

Director, Divisional Research, Shannon E. Wilkes Targeted Therapy Program; The Jeffrey A. Barbour Chair for Pediatric Hematology/Oncology Research and Healing; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.